Decreased ADAMTS13 activity leads to a buildup of the ultra large vWF multimers along endothelial walls, resulting in platelet-rich microthrombi and the characteristic triad of thrombocytopenia, hemolytic anemia, and end-organ ischemia characterizing the disease. Here, ADAMTS13 is linked to Thrombocytopenia.